For help on how to get the results you want, see our search tips.
4863 results
Medicine
Orphan designations Remove Orphan designations filter
Periodic safety update report single assessments Remove Periodic safety update report single assessments filter
Categories
Human Remove Human filter
-
List item
Orphan designation: autologous dendritic cells pulsed with killed ovarian cancer cells and matured by TLR3 ligand ex vivo for: Treatment of ovarian cancer (updated)
Date of designation: 16/04/2018, Withdrawn, Last updated: 17/08/2022 -
List item
Orphan designation: Recombinant truncated N-terminal fragment of human lens epithelium-derived growth factor for: Treatment of retinitis pigmentosa (updated)
Date of designation: 23/08/2017, Withdrawn, Last updated: 12/08/2022 -
List item
Orphan designation: allogeneic peripheral blood mononuclear cells incubated ex-vivo with 16, 16-dimethyl prostaglandin E2, dexamethasone for: Treatment in haematopoietic stem cell transplantation (updated)
Date of designation: 18/11/2016, Withdrawn, Last updated: 10/08/2022 -
List item
Orphan designation: N-(2,4-di-tert-butyl-5-hydroxyphenyl)-1,4-dihydro-4-oxoquinoline-3-carboxamide (ivacaftor) for: Treatment of cystic fibrosis (updated)
Date of designation: 08/07/2008, Expired, Last updated: 10/08/2022 -
List item
Orphan designation: recombinant adeno-associated viral vector serotype 2 carrying the gene for the human aromatic L-amino acid decarboxylase protein, Eladocagene exuparvovec for: Treatment of aromatic L-amino acid decarboxylase deficiency (updated)
Date of designation: 18/11/2016, Positive, Last updated: 10/08/2022 -
List item
Orphan designation: 2-Chloro-N6-(3-iodobenzyl)adenosine-5'-N-methyluronamide (namodenoson) for: Treatment of hepatocellular carcinoma (updated)
Date of designation: 09/10/2015, Positive, Last updated: 10/08/2022 -
List item
Orphan designation: Adenovirus associated viral vector serotype 4 containing the human RPE65 gene for: Treatment of retinitis pigmentosa (updated)
Date of designation: 14/11/2007, Positive, Last updated: 09/08/2022 -
List item
Orphan designation: Adenovirus associated viral vector serotype 4 containing the human RPE65 gene for: Treatment of Leber's congenital amaurosis (updated)
Date of designation: 22/10/2007, Positive, Last updated: 09/08/2022 -
List item
Orphan designation: adenovirus associated viral vector serotype 5 containing the human pde6β gene for: Treatment of retinitis pigmentosa (updated)
Date of designation: 19/06/2013, Positive, Last updated: 09/08/2022 -
List item
Orphan designation: Adeno-associated viral vector serotype 5 containing the human RLBP1 gene for: Treatment of retinitis pigmentosa (updated)
Date of designation: 14/10/2016, Positive, Last updated: 09/08/2022 -
List item
Orphan designation: Mazindol for: Treatment of narcolepsy (updated)
Date of designation: 09/10/2015, Positive, Last updated: 03/08/2022 -
List item
Orphan designation: Bilayer engineered collagen hydrogel-based skin graft composed of autologous keratinocytes and fibroblasts for: Treatment of partial deep dermal and full-thickness burns (updated)
Date of designation: 14/12/2015, Positive, Last updated: 03/08/2022 -
List item
Orphan designation: Recombinant human alpha-glucosidase conjugated with multiple copies of synthetic bismannose-6-phosphate-tetra-mannose glycan (avalglucosidase alfa) for: Treatment of glycogen storage disease type II (Pompe's disease) (updated)
Date of designation: 26/03/2014, Withdrawn, Last updated: 02/08/2022 -
List item
Orphan designation: Pegylated recombinant arginine deiminase (pegargiminase) for: Treatment of malignant mesothelioma (updated)
Date of designation: 15/01/2015, Positive, Last updated: 02/08/2022 -
List item
Orphan designation: (S)-ethyl 2-amino-3-(4-(2-amino-6((R)-1-(4-chloro-2-(3-methyl-1H-pyrazol-1-yl)phenyl)-2,2,2-trifluoroethoxy)pyrimidin-4-yl)phenyl)propanoate for: Treatment of carcinoid syndrome (updated)
Date of designation: 30/05/2016, Positive, Last updated: 28/07/2022 -
List item
Orphan designation: Recombinant human acid sphingomyelinase (also known as olipudase alfa) for: Treatment of Niemann-Pick disease (updated)
Date of designation: 24/06/2022, Positive, Last updated: 27/07/2022 -
List item
Orphan designation: Moxetumomab pasudotox for: Treatment of B-lymphoblastic leukaemia/lymphoma (updated)
Date of designation: 19/07/2022, Withdrawn, Last updated: 25/07/2022 -
List item
Orphan designation: Adeno-associated viral vector serotype 9 containing the human SMN gene (onasemnogene abeparvovec) for: Treatment of spinal muscular atrophy (updated)
Date of designation: 19/06/2015, Positive, Last updated: 25/07/2022